Optimizing Antibody-Drug Conjugates With Computational Modelling

Optimizing antibody-drug conjugates with computational modelling

Accelerating Antibody Drug Discovery Through Computational Modeling

The Antibody Society

Simple and effective tools for antibody-drug conjugate screening and characterization

Optimize your Antibody Drug Conjugates with Shielded Linkers. Create Happy ADC’s!

Vector Laboratories Inc

Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody–drug conjugates

Elsevier for Life Sciences

Antibody-drug Conjugates in the Clinic:

Optimize your Antibody Drug Conjugates with Shielded Linkers. Create Happy ADC’s!

Vector Laboratories Inc

What are Antibody Drug Conjugates (ADCs)?

Computational Antibody Discovery Symposium: Ben Holland (CTO, Antiverse)

The Antibody Society

Challenges and Advances in Antibody-Drug Conjugates.

BioPharma Nexus Conference

SMARTag™ Antibody Drug Conjugate Technology | Why Catalent?

Catalent Pharma Solutions

The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma

Touch Medical Media

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

10/17/2018 Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

GenScript USA Inc.

Integrated Antibody Drug Discovery Lead Generation, Characterization, and Optimization

GenScript USA Inc.

Computational Antibody Discovery Symposium: Panel discussion summary

The Antibody Society

Biopharmaceutical Informatics Symposium - Dr. Konrad Krawczyk, Natural Antibody

The Antibody Society

Antibody-drug Conjugate-Precision Targeted Therapy - Creative Biolabs

Creative Biolabs

Integrated Strategies to Accelerate Preclinical Development of Antibody-Drug Conjugates

WuXi Discovery Services

Using Modeling and Simulation to Optimize Dosing of an Anti-Infective for Children